{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:17:54Z","timestamp":1774289874460,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.psyneuen.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T06:57:48Z","timestamp":1550732268000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Adiponectin levels in patients with bipolar disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"104","author":[{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Stramecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Kasznia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Lis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart\u0142omiej","family":"Sta\u0144czykiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2019.02.019_bib0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2265.2006.02628.x","article-title":"Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism","volume":"65","author":"Altinova","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","article-title":"Increased levels of adipokines in bipolar disorder","volume":"46","author":"Barbosa","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psyneuen.2015.03.012","article-title":"Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis","volume":"56","author":"Bartoli","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/wps.20441","article-title":"Staging in bipolar disorder: from theoretical framework to clinical utility","volume":"16","author":"Berk","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4088\/JCP.15m10189","article-title":"A longitudinal study of the relationships between mood symptoms, body mass index, and serum adipokines in bipolar disorder","volume":"78","author":"Bond","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0040","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/ern.10.185","article-title":"Insulin dysfunction and allostatic load in bipolar disorder","volume":"11","author":"Brietzke","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0029-1246118","article-title":"Effect of triiodothyronine on adiponectin expression and leptin release by white adipose tissue of normal rats","volume":"42","author":"Cabanelas","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2018.05.008","article-title":"Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis","volume":"238","author":"Cao","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2014.08.002","article-title":"Adipokines as emerging depression biomarkers: a systematic review and meta-analysis","volume":"59","author":"Carvalho","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0060","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00023210-200822080-00004","article-title":"Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden","volume":"22","author":"Fagiolini","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","article-title":"Adiponectin and inflammation: consensus and controversy","volume":"121","author":"Fantuzzi","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2016.02.003","article-title":"Leptin in bipolar disorder: a systematic review and meta-analysis","volume":"35","author":"Fernandes","year":"2016","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0090","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0095","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2265.2007.02963.x","article-title":"Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder","volume":"67","author":"Hung","year":"2007","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cyto.2007.10.001","article-title":"Influence of thyroid dysfunction on serum concentrations of adipocytokines","volume":"40","author":"Iglesias","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/acps.12305","article-title":"Staging systems in bipolar disorder: an international society for bipolar disorders task force report","volume":"130","author":"Kapczinski","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. Late-stage bipolar disorder","volume":"12","author":"Kauer-Sant\u2019Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0115","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.4088\/JCP.8125tx11c","article-title":"Diagnostic features, prevalence, and impact of bipolar disorder","volume":"71","author":"Ketter","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0120","doi-asserted-by":"crossref","first-page":"12248","DOI":"10.1073\/pnas.1202835109","article-title":"Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2007.12.233","article-title":"Prevalence and correlates of overweight in drug-na\u00efve patients with bipolar disorder","volume":"110","author":"Maina","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpsychires.2015.12.003","article-title":"Adipokines, metabolic dysfunction and illness course in bipolar disorder","volume":"74","author":"Mansur","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/pcn.12535","article-title":"Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder","volume":"71","author":"Mansur","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0155","first-page":"658913","article-title":"New insight into adiponectin role in obesity and obesity-related diseases","author":"Nigro","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0160","first-page":"1","article-title":"Effects of antidepressants and mood stabilizers on serum levels of adiponectin","volume":"33","author":"Omata","year":"2012","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0165","first-page":"1","article-title":"Adiponectin is decreased in bipolar depression","volume":"20","author":"Platzer","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0170","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm1029","article-title":"Adiponectin acts in the brain to decrease body weight","volume":"10","author":"Qi","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ijnp\/pyy062","article-title":"Kinetics of cytokine levels during antipsychotic treatment in schizophrenia: a meta-analysis","volume":"21","author":"Romeo","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/acps.12414","article-title":"Are medical comorbid conditions of bipolar disorder due to immune dysfunction?","volume":"132","author":"Rosenblat","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2016.12.059","article-title":"Medical comorbidity in bipolar disorder: the link with metabolic-inflammatory systems","volume":"211","author":"SayuriYamagata","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12017-010-8140-8","article-title":"Mood disorders and obesity: understanding inflammation as a pathophysiological nexus","volume":"13","author":"Soczynska","year":"2011","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2014.02.005","article-title":"Lithium decreases plasma adiponectin levels in bipolar depression","volume":"564","author":"Soeiro-de-Souza","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2018.11.075","article-title":"Plasma levels of leptin and adiponectin and depressive symptoms in young adults","volume":"272","author":"Syk","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2011.01560.x","article-title":"Adiponectin receptor signalling in the brain","volume":"165","author":"Thundyil","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/08039488.2017.1402953","article-title":"Adipocytokines and ghrelin level of bipolar patients from manic episode to euthymic episode","volume":"72","author":"Tun\u00e7el","year":"2018","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0220","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jad.2016.06.016","article-title":"The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: a systematic review","volume":"203","author":"van den Ameele","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0235","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.psychres.2015.09.040","article-title":"Right hippocampus size is negatively correlated with leptin serum levels in bipolar disorder","volume":"230","author":"Vianna-Sulzbach","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0240","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw012","article-title":"The differential levels of inflammatory cytokines and bdnf among bipolar spectrum disorders","volume":"19","author":"Wang","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.20156","article-title":"Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment","volume":"16","author":"Warner-Schmidt","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0250","series-title":"Newcastle-Ottawa Scale Assess. Qual. Nonrandomised Stud. Meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.psyneuen.2019.02.019_bib0255","doi-asserted-by":"crossref","first-page":"44913","DOI":"10.1074\/jbc.M111.310052","article-title":"Adiponectin stimulates proliferation of adult hippocampal neural stem\/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)\/glycogen synthase kinase 3\u03b2 (GSK-3\u03b2)\/\u03b2-catenin signaling cascade","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019300873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019300873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:03:50Z","timestamp":1759683830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019300873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"alternative-id":["S0306453019300873"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.02.019","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin levels in patients with bipolar disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}